Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Jyh Jou Chen"'
Autor:
Hung-Da Tung, Jyh-Jou Chen
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 9, Pp 926-933 (2024)
Unlike hepatitis C virus (HCV) genotype (GT) 6, which is widely circulated in Southeast Asia and South China, GT 6 was not reported in Taiwan until 2006. GT 1b and 2a, also known as global HCV subtypes, have been reported as major GTs circulating in
Externí odkaz:
https://doaj.org/article/7e19a62a0bee4cd4b4ec2e83be9b8a34
Autor:
Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, Hsing-Tao Kuo, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi‐Ming Tai, Chih-Wen Lin, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Chi-Yi Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chung, Ming-Jong Bair, Ming-Lung Yu, T-COACH Study Group
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 3, Pp 468-486 (2024)
Background/Aims Chronic hepatitis C (CHC) patients who failed antiviral therapy are at increased risk for hepatocellular carcinoma (HCC). This study assessed the potential role of metformin and statins, medications for diabetes mellitus (DM) and hype
Externí odkaz:
https://doaj.org/article/c4b167d9986a4d858ee7c5d56f112a9c
Publikováno v:
Physiological Reports, Vol 12, Iss 15, Pp n/a-n/a (2024)
Abstract This study investigated the ability of a sarcopenia screening test to predict mortality among cancer inpatients. We conducted a prospective study of patients admitted to the oncology ward of a teaching hospital in southern Taiwan. Over a 5
Externí odkaz:
https://doaj.org/article/c3f8f942febb409bbb40a01990e0fe1e
Autor:
Chi‐Yi Chen, Wan‐Long Chuang, Albert Qin, Wen‐Hua Zhang, Li‐Ying Zhu, Guo‐Qiang Zhang, Jyh‐Jou Chen, Ching‐Chu Lo, Xinmin Zhou, Xiaorong Mao, Jia Shang, Hsing‐Tao Kuo, Wen Xie, Chien‐Hung Chen, Gin‐Ho Lo, Dae W Jun, Shuangsuo Dang, Chan‐Yen Tsai, Ting‐Fang Wang, Hsin‐Hui Lai, Kuan‐Chiao Tseng, Yi‐Wen Huang, Pei‐Jer Chen
Publikováno v:
JGH Open, Vol 6, Iss 11, Pp 782-791 (2022)
Abstract Background and Aim Ropeginterferon alfa‐2b is a novel mono‐pegylated, extra‐long‐acting interferon. It is administered infrequently and showed good tolerability and clinical activity for the chronic hepatitis B or C treatment in our
Externí odkaz:
https://doaj.org/article/b7057a2e69a042f3b15c1e087a8e6413
Autor:
Jyh-Jou Chen, Yen-Cheng Chiu, Pei-Lun Lee, Hung-Da Tung, Hung-Chih Chiu, Shih-Chieh Chien, Pin-Nan Cheng
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 11, Pp 2265-2272 (2022)
Background: Hepatitis C virus (HCV) genotype 6 mainly distributes in Southeast Asia and South China. Because of the low prevalence in developed countries, optimal treatment for HCV genotype 6 in real-world setting remains to be determined. We aimed t
Externí odkaz:
https://doaj.org/article/6853a350bfaf49a797de5617009dae45
Autor:
Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, Chun-Jen Liu, Ching-Chu Lo, Ke-Jhang Huang, Jyh-Jou Chen, Kuo-Chih Tseng, Chi-Yang Chang, Cheng-Yuan Peng, Yu-Lueng Shih, Chia-Sheng Huang, Wei-Yu Kao, Sheng-Shun Yang, Ming-Chang Tsai, Jo-Hsuan Wu, Po-Yueh Chen, Pei-Yuan Su, Jow-Jyh Hwang, Yu-Jen Fang, Pei-Lun Lee, Chi-Wei Tseng, Fu-Jen Lee, Hsueh-Chou Lai, Tsai-Yuan Hsieh, Chun-Chao Chang, Chung-Hsin Chang, Yi-Jie Huang, Jia-Horng Kao
Publikováno v:
Clinical and Molecular Hepatology, Vol 27, Iss 4, Pp 575-588 (2021)
Background/Aims Real-world studies assessing the effectiveness and safety of sofosbuvir/velpatasvir (SOF/VEL) plus ribavirin (RBV) for Child-Pugh B/C hepatitis C virus (HCV)-related cirrhosis are limited. Methods We included 107 patients with Child-P
Externí odkaz:
https://doaj.org/article/4ef4e404f00c418597db8898e8c2d587
Geographic variation of genotype 6 hepatitis C virus infection in an endemic area of southern Taiwan
Autor:
Hung-Da Tung, Pei-Lun Lee, Jyh-Jou Chen, Hsing-Tao Kuo, Ming-Jen Sheu, Chun-Ta Cheng, Tang-Wei Chuang, Hsu-Ju Kao, Chia-Yi Hou, Hsin-Hua Tsai, Li-Ching Wu, Chuan Lee
Publikováno v:
Journal of the Formosan Medical Association, Vol 119, Iss 12, Pp 1876-1880 (2020)
Taiwan is a hepatitis C virus (HCV) endemic country with geographic variation of prevalence and main genotypes(GTs) are 1 b and 2a. We recently reported high GT6 prevalence in Tainan of southern Taiwan. To clarify this special genotype as a local end
Externí odkaz:
https://doaj.org/article/7261726bebb64d72a2d0cb60aafb5e11
Autor:
Jyh-Jou Chen, Hung-Da Tung, Pei-Lun Lee, Hsing-Tao Kuo, Ming-Jen Sheu, Chun-Ta Cheng, Tang-Wei Chuang, Hsu-Ju Kao, Na-Mi Lu, Li-Ching Wu, Chuan Lee
Publikováno v:
Journal of the Formosan Medical Association, Vol 119, Iss 1, Pp 413-419 (2020)
Background/Purpose: Abbott RealTime Genotype II assay can effectively identify hepatitis C virus (HCV) genotypes (GTs), but some GT 6 subtypes might not be differentiated from GT 1. Abbott RealTime Genotype II PLUS and sequencing might be needed to r
Externí odkaz:
https://doaj.org/article/06f2c2c37e8240ed98bd3af3d4a28a5d
Publikováno v:
Frontiers in Nutrition, Vol 8 (2021)
Dietary behavior is a critical lifestyle factor affecting health. This study aimed to investigate food away from home (FAFH) and its effect on gastrointestinal (GI) health. A questionnaire-based survey was conducted with 300 participants at a hospita
Externí odkaz:
https://doaj.org/article/22d96a8c46e5413086a3c53a12ed708e
Autor:
Chen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, Tsai-Yuan Hsieh, Yi-Hsiang Huang, Wei-Wen Su, Pin-Nan Cheng, Chih-Lin Lin, Ching-Chu Lo, Chi-Yi Chen, Jyh-Jou Chen, Qian Ma, Craig Brooks-Rooney, Jia-Horng Kao
Publikováno v:
Journal of the Formosan Medical Association, Vol 118, Iss 6, Pp 1014-1023 (2019)
Background/Purpose: While direct-acting antiviral regimens have been approved for chronic hepatitis C (CHC) patients in Taiwan, reimbursement is limited to certain populations. Thus, pegylated interferon plus ribavirin (PEG-IFN/RBV) remains the stand
Externí odkaz:
https://doaj.org/article/daef8329372b4c10aaf0cc4a4b621cef